REPL: Replimune Group Inc

REPL haberleri

• Investing 10:57 Cantor Fitzgerald initiates Replimune stock with overweight rating
• Seeking Alpha 01:14 Tracking Baker Brothers Portfolio – Q1 2025 Update
• Investing 20:16 Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Investing 14:55 JPMorgan reiterates overweight rating on Replimune stock after ASCO
• Investing 11:34 Piper Sandler raises Replimune stock price target after updates
• Investing 14:12 Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
• Investing 13:44 Replimune to Present at the 2025 Jefferies Global Healthcare Conference
• Investing 01:49 Replimune director sells $260,168 in common stock
• Investing 01:45 Replimune’s chief commercial officer sells $30,179 in stock
• Investing 12:56 Earnings call transcript: Replimune Q1 2025 sees stock drop post-earnings
• Investing 11:20 Replimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
• Investing 18:01 Tesla, Amer Sports Lead Market Cap Stock Movers on Tuesday
• Investing 12:20 Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day
• Benzinga 14:36 Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Beam Therapeutics (NASDAQ:BEAM), B2Gold (AMEX:BTG)
• Seeking Alpha 16:02 Iovance: The Company Makes It Hard To Estimate Revenue Growth (NASDAQ:IOVA)
• Seeking Alpha 03:56 Tracking Baker Brothers Portfolio - Q4 2024 Update
• Seeking Alpha 21:21 Replimune: A Misunderstood Contender In Oncolytics (NASDAQ:REPL)
• Benzinga 12:25 Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Celestica (NYSE:CLS), Dogness (Intl) (NASDAQ:DOGZ)